ARTICLE | Company News
Neurotech licenses Amgen's CNTF
January 14, 2002 8:00 AM UTC
Neurotech (Paris, France) obtained an exclusive license to ciliary neurotrophic factor ( CNTF) from AMGN for ophthalmic indications. AMGN will receive Neurotech warrants, and Neurotech will receive upfront payments and milestones, and is eligible for royalties. ...